The pharmaceutical industry, with its stringent regulations, demands that healthcare professionals (HCPs) often have to navigate complex onboarding processes to access digital platforms.
Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisatio
Healthcare professionals (HCPs) rate websites as their number one source for clinical practice information and mobile technology has cemented this, with half of HCPs accessing such resource
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
